Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Flu Vaccines
NCT03028974Phase 4Completed
- Sponsor
- Stanford University
- Start
- Sep 2014
- Primary completion
- Nov 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal), Fluzone Trivalent in influenza, sponsored by Stanford University. Started Sep 2014; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03028974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028974.